Vertex Pharmaceuticals, under the leadership of CEO Reshma Kewalramani, was named in the “Impact Awards” category, which spotlights five standout companies making meaningful advancements in their ...

The controversial drugs are not yet approved by federal regulators, but advocates hope a NC law would allow the state to be ...

The Food and Drug Administration is reconsidering its decision not to approve a drug that an Omaha mom says is saving her son ...

For Sarepta, the hits keep coming, with several downgrades in the past week after it was forced to temporarily take its ...

PepsiCo and Dr Pepper have sold versions of their flagship sodas sweetened with cane sugar since 2009. Coca-Cola has sold ...

Elevated levels of lead and cadmium can cause significant health problems, particularly among infants and children.

U.S. Food and Drug Administration employees told CNN that Elsa — the AI model that’s supposed to help speed up approvals of pharmaceuticals and medical devices — isn’t working great. Instead, it cites ...

In 2022, President Joe Biden signed The Modernization of Cosmetic Regulations Act, or MoCRA, into law, which expanded FDA ...

Earlier this year, the FDA unveiled Elsa, an artificial intelligence tool that's expected to speed up the process for approving drugs and medical devices. The problem? According to some current FDA ...

The affected bars were distributed in 23 states: Florida, California, Pennsylvania, Ohio, Georgia, New York, New Jersey, Texas, Virginia, Arizona, Alabama, Wisconsin, Illinois, Missouri, Massachusetts ...

The Food and Drug Administration won’t sign off on Sarepta Therapeutics Inc. bringing its controversial gene therapy back to ...

Learn how ATTR-CM is treated with medications that slow down the condition's progression and other therapies that reduce symptoms and improve the quality of life.